Powder Delivery TRIZ Cases

Cyclodextrin inclusion complexes protect xanthohumol from isoxanthohumol conversion during hot-melt extrusion, enhancing bioavailability.

Specific phenolic derivatives stabilize proteins against heat-induced breakdown, enabling durable industrial materials.

Creatinine excipients reduce viscosity by 10-70% and prevent aggregation in high-concentration therapeutic protein solutions.

Applying copper compound compositions to damaged skin promotes wound healing and reduces inflammatory cytokine secretion.

Amorphous silica shell encapsulates virus via sol-gel deposition, eliminating cold-chain storage costs while maintaining viability.

Chitosan-OEGCG lycopene nanoparticles suppress osteoclast differentiation to improve bone density while avoiding bisphosphonate side effects.

New ionizable lipids featuring hydrolyzable ester bonds enhance mRNA encapsulation and cellular uptake within lipid nanoparticles.

Transition metal salts adsorb onto nanoscale organic particles to prevent agglomeration and sedimentation, ensuring sustained bioavailability.

pH-responsive linkers release therapeutic payloads in acidic tumor microenvironments to reduce off-target toxicity.

Oral microbiota restoration therapy compositions utilize lyophilization and encapsulation to deliver purified stool samples.

Acrylate-modified fluoropolymers increase surface friction to resolve securement issues and enable tunable drug permeation from medical implants.

A freeze-dried fruit and vegetable composition preserves active ingredients in a crunchy, orally disintegrable solid form.

Optimized acid buffers and polyols prevent protein aggregation during storage, maintaining antibody potency.

A polysaccharide-vitamin conjugate shell encapsulates hydrophobic active agents in a core portion to enable parenteral administration.

Packaging maintains 3% to 7% moisture in prostacyclin analogs, reducing degradation and eliminating excessive desiccants.

Polyvinylpyrrolidone-coated germanium telluride nanosheets resolve side effect contradictions by targeting inflammatory sites locally.

Polymeric carriers exploit acidic joint environments to release drugs locally, reducing systemic toxicity from non-specific distribution.

A herbal composition of Ganoderma, ginseng, and fermented Cordycesin increases peripheral leucocyte counts.

Inorganic quantum dots generate reactive oxygen species to kill multidrug-resistant bacteria without causing cytotoxicity.

Platinum nanoparticles dispersed in electrolyzed water increase Akkermansia muciniphila concentration, strengthening the intestinal mucosal barrier.

Amorphous microporous silica matrices resolve dose dumping and burst effects by using 0.4 to 2.0 nm pores for predictable gastrointestinal targeting.

Mangiferin reduces gold salts to form stable nanoparticles that suppress NF-kB activation in castration-resistant prostate cancer.

A rhodium-loaded porphyrin complex neutralizes opioid biological activity through intracellular signaling inhibition and ion channel deactivation.

Controlling API particle size and crystal structure resolves the contradiction between rapid dissolution and clinical reliability.

A catechin and polyethylene glycol nanocomposite stabilizes corneal epithelial cells.

Liposome-encapsulated CFTR mRNA bypasses immune responses and nuclear import barriers to restore chloride channel activity in cystic fibrosis.

A pharmaceutical composition containing proenzymes and enzymes targets cancer tumors with selective action.

A dietary supplement combines prebiotic yeast, immune effector proteins, and probiotics to stimulate host immunity.

Ultrasmall nanoparticles conjugated with PSMA inhibitors enable precise molecular targeting of prostate cancer cells.

Reducing mannitol bulk density via mass breaking resolves flowability trade-offs while ensuring complete dissolution.

Poloxamer stabilizers suppress enzyme aggregation to enable effective intrathecal delivery across the blood-brain barrier.

L-phenylalanine-functionalized mesoporous silica nanoparticles exploit LAT-1 transporters to selectively target cancer cells.

Porous nanoparticles with quaternary ammonium cores adsorb proteins for direct cytosol delivery, bypassing complex pH adjustments and nanocapsule formation.

Nepovirus coat protein fusion polypeptides form stable virus-like particles without complex subunit assembly.

Albumin and collagen stabilizers shield live attenuated dengue virus from thermal degradation, enabling refrigerated storage at 2-8°C.

Covalent heterobivalent inhibitors bind IgE antibodies to block allergic degranulation.

Pre-incorporating drugs into the polymer backbone ensures batch consistency and bypasses multidrug resistance efflux pumps.

Self-assembled neutrophil membrane-coated aspirin nanoparticles improve bioavailability and reduce side effects in arthritis treatment.

Continuous impregnation process accumulates active pharmaceutical ingredients onto porous carriers with surface areas exceeding 400 m2/g.

Optimized ionizable cationic lipids enhance mRNA transfection efficiency while reducing systemic toxicity through tailored hydrophobic tail configurations.

Silica particles incorporate light upconversion molecules to convert low-energy near-infrared photons into visible light, enabling photocatalyst activation.

A caspofungin diacetate composition uses a carbonate buffering agent to maintain pharmaceutical stability during storage.

Polymer nanogels deliver antibodies intracellularly via redox-sensitive linkers to trigger specific endogenous protein degradation.

Targeting N-terminal amino groups with branched aldehyde PEG extends circulation half-life while preserving catalytic activity.

Blank silane-derived sol-gel particles form first, then load sensitive drugs to prevent degradation while enabling controlled release profiles.

Lyophilized alphavirus formulations use amorphous sugar matrices to protect viral particles during drying and storage.

Magnetic beads capture microvesicles to replace slow ultracentrifugation, enabling scalable RNA isolation.

Exogenous diamine oxidase degrades ingested histamine before alcohol inhibits endogenous activity, preventing headache and nausea.

A Factor IX-FcRn fusion protein formulation extends circulating half-life through receptor-mediated recycling.